Envolvimento Cerebeloso Atípico na Doença Associada ao Anticorpo Anti-MOG na Infância
DOI:
https://doi.org/10.46531/sinapse/IN/230001/2023Palavras-chave:
Anticorpos, Criança, Encefalomielite Aguda Disseminada/diagnóstico por imagem, Encefalomielite Aguda Disseminada/tratamento farmacológico, Glicoproteína Mielina- OligodendrócitoDownloads
Referências
Zhang M, Shen J, Zhou S, Du X, Li W, Yu L, et al. Clinical and neuroimaging characteristics of pediatric acute disseminating encephalomyelitis with and without antibodies to myelin oligodendrocyte glycoprotein. Front Neurol. 2020;11:593287. doi:10.3389/fneur.2020.593287.
Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immunemediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19:12617. doi: 10.1177/1352458513484547.
Armindo RD, Healion E, Palavra F. The spectrum of antiMOG associated demyelinating diseases in children: a review illustrated with clinical cases. Sinapse. 2020;20:17-24. doi: 10.46531/sinapse/AR/200002/2020.
Baumann M, Sahin K, Lechner C, Hennes EM, Schanda K, Mader S, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry. 2015;86:265-72. doi: 10.1136/jnnp-2014-308346.
